| Pharmaceutical active ingredients: |
| Mesalamine |
| Available forms, composition and doses of Enterasin: |
| N / A |
| Enterasin medical category: |
| Human:Anti-inflammatory agentsGIT regulators, antiflatulents and anti-inflammatories |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07EC02 - Mesalazine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Crinos |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Entepas | Aminosalicylic Acid (Aminosalicylate) | Unidentified Pharmaceutical Company |
| Entera | Preparation for Enteral Nutrition | Fresenius; Rowa Pharmaceuticals |
| Enteral | Ranitidine | Vargas Laboratorios |
| Enteral 400 | Preparation for Enteral Nutrition | SHS International |
| Enteramida | Anileridine | Unidentified Pharmaceutical Company |
| Entera-Strept Cumsulfa | Dihydrostreptomycin Sulfate; Sulfaguanidine | Heyl Chemisch-Pharmazeutische Fabrik |
| Entercal | Attapulgite; Sulfamethoxazole; Trimethoprim | Luper Industria Farmaceutica |
| Entercine | Broxyquinoline; Dihydrostreptomycin Sulfate; Homatropine Methylbromide; Sulfaguanidine | Biogalenique Laboratoires |
| Entereg | Alvimopan | Adolor; GlaxoSmithKline |
| Enterex | Preparation for Enteral Nutrition | Recalcine Laboratorios; Pisa Laboratorios |